What happens to the FDA if the government shuts down?; Covidien to report Q4 on Nov. 8;

@FierceMedDev:  | Follow @FierceMedDev

@MarkHFierce: KKR made it official, grabbing an 80% stake of Panasonic's healthcare arm for $1.67B - much higher than predicted. ICYMI Friday | Follow @MarkHFierce

@MichaelGFierce: ICYMI: Medtronic lands U.S. approval of early-generation artificial pancreas. Story from FierceDrugDelivery | Follow @MichaelGFierce

> If a government shutdown comes as expected on Oct. 1, the FDA will lose 6,620 employees, about 45% of its staff. The agency would also have to cease many inspections, enforcement actions and monitoring operations. Story

> Covidien ($COV), which has announced plans for layoffs and plant closings, will report its fourth-quarter results on Nov. 8, 2013. Item

> Micell Technologies said that the American College of Cardiology's Cardiovascular Interventions Journal will publish a peer-reviewed article discussing results from the DESSOLVE I trial of its new drug-eluting absorbable polymer coronary stent system. Item

> Critical Diagnostics is touting the results of a new study that showed ST2 is a better biomarker than Galectin-3 to help diagnose and treat heart failure patients. (The company produces an ST2 assay.) Item

> Canada's Amulyte wants to raise $2 million through crowdfunding to help develop an emergency alert device for senior citizens. Story

Biotech News

@FierceBiotech: AstraZeneca CEO celebrates 1st anniversary with promising lung cancer data. More | Follow @FierceBiotech

@JohnCFierce: Pfizer nabs autoimmune disease drug rights for $25M upfront. News | Follow @JohnCFierce

@DamianFierce: Few are optimistic about a last-minute budget deal. Here's what happens at the FDA after a shutdown: Article | Follow @DamianFierce

> Lundbeck to cull 200 staffers in cost-cutting drive. Item

> Relypsa pitches $126M IPO as lead CKD drug nears moment of PhIII truth. Story

> Achillion shares crushed in a rout as hep C blockbuster hopes fade. Article

> Roche's new round of lung cancer data keeps spotlight on immunotherapies. More

Pharma News

@FiercePharma: Trending on our website (still): If  reps can't get in doctors' front doors, try alternate routes. Story | Follow @FiercePharma

@EricPFierce: U.K. tosses lean, but important bone to  with expected extension of cancer drug fund. ICYMI Friday | Follow @EricPFierce

@CarlyHFierce: Bristol-Myers melanoma drug Yervoy helps patients live years longer, study finds. Story  | Follow @CarlyHFierce

> Germany's Bayer taps Pfizer's Olivier Brandicourt to head Bayer HealthCare. News

> Look out, pharma marketers. Obamacare will change your lives. More

> Roche CEO: 'Extremely' open to talk with Novartis about teaming up. Article

CRO News

> Quintiles jumps into personalized medicine for cancer trials. More

> Merged at last, PRA and RPS say they're fourth-largest CRO. Report

> InVentiv launches doc network for late-stage trials. Story

> JSS snaps up Latin American CRO. Article

> Parexel launches China-focused service as local demand heats up. News

Biotech IT News

> FDA taking hands-off approach to regulation of most apps. More

> Genohub talks up 'Kayak' for NGS services. Report

> NIH calls for comments on draft genomics data sharing policy. Story

> Business behind Google Earth for the human body raises $4M. Item

> Pfizer to give patients access to their trial data. Article